SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-22-006029
Filing Date
2022-08-23
Accepted
2022-08-23 21:48:33
Documents
1
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2165
  Complete submission text file 0001683168-22-006029.txt   3742
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Issuer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ATRINSIC, INC. 1 GRAND CENTRAL PLACE SUITE 2319 NEW YORK NY 10165
Business Address
SCHECHTER JONATHAN (Reporting) CIK: 0001619259 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40699 | Film No.: 221188710